ARYx Financial Statements
ARYx Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
ARYx Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 4.2 | 4.7 | 0.0 |
| Gross Profit ($ mil.) | 3.9 | 2.6 | -- |
| Operating Income ($ mil.) | (28.8) | (28.3) | (28.2) |
| Total Net Income ($ mil.) | (27.6) | (27.3) | (28.0) |
| Diluted EPS (Net Income) | (8.24) | (26.84) | (30.73) |
ARYx Stock Quote & Chart
08/21/08 14:59:15 EST •
NASDAQ •
6.22
•
 +0.0900
•
+1.4682 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
ARYx Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 28.76 | 3.75 | 1.56 |
| Price/Earnings Ratio | -- | 16.34 | 15.82 |
| Price/Book Ratio | 3.38 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed ARYx Financial Ratios
ARYx Competitive Intelligence
| Bayer HealthCare Pharmaceuticals | Cardiome | Novartis Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,258.9 | 4.8 | 754.3 |
| Employees | 2,000 | -- | 7,000 |
| Market Cap ($ mil.) | -- | -- | -- |
Competitive Landscape
